Literature DB >> 12077608

Early detection and response to meningococcal disease epidemics in sub-Saharan Africa: appraisal of the WHO strategy.

J A D Leake1, M L Kone, A A Yada, L F Barry, G Traore, A Ware, T Coulibaly, A Berthe, H Mambu Ma Disu, N E Rosenstein, B D Plikaytis, K Esteves, J Kawamata, J D Wenger, D L Heymann, B A Perkins.   

Abstract

OBJECTIVE: To assess the sensitivity, specificity and predictive value positive of the WHO threshold strategy for detecting meningococcal disease epidemics in sub-Saharan Africa and to estimate the impact of the strategy on an epidemic at district level.
METHODS: Data on meningitis cases at the district level were collected weekly from health ministries, WHO country and regional offices, and nongovernmental organizations in countries where there were epidemics of meningococcal disease in 1997. An epidemic was defined as a cumulative district attack rate of at least 100 cases per 100,000 population from January to May, the period of epidemic risk. The sensitivity, specificity and predictive value positive of the WHO threshold rate were calculated, and curves of sensitivity against (1 - specificity) were compared with alternatively defined threshold rates and epidemic sizes. The impact of the WHO strategy on a district epidemic was estimated by comparing the numbers of epidemic cases with cases estimated to have been prevented by vaccination.
FINDINGS: An analysis was made of 48 198 cases reported in 174 districts in Benin, Burkina Faso, the Gambia, Ghana, Mali, Niger, and Togo. These cases were 80.3% of those reported from Africa to WHO during the 1997 epidemic period. District populations ranged from 10,298 to 573,908. The threshold rate was crossed during two consecutive weeks in 69 districts (39.7%) and there were epidemics in 66 districts (37.9%). Overall, the sensitivity of the threshold rate for predicting epidemics was 97%, the specificity was 95%, and the predictive value positive was 93%. Taken together, these values were equivalent or better than the sensitivity, specificity and predictive value positive of alternatively defined threshold rates and epidemics, and remained high regardless of district size. The estimated number of potential epidemic cases decreased by nearly 60% in the age group targeted for vaccination in one district where the guidelines were followed in a timely manner.
CONCLUSION: The use of the WHO strategy was sensitive and specific for the early detection of meningococcal disease epidemics in countries of sub-Saharan Africa during 1997 and had a substantial impact on a district epidemic. Nevertheless, the burden of meningococcal disease in these countries remains formidable and additional control measures are needed.

Entities:  

Mesh:

Year:  2002        PMID: 12077608      PMCID: PMC2567794     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  10 in total

1.  A Bayesian network approach to the study of historical epidemiological databases: modelling meningitis outbreaks in the Niger.

Authors:  A Beresniak; E Bertherat; W Perea; G Soga; R Souley; D Dupont; S Hugonnet
Journal:  Bull World Health Organ       Date:  2012-01-20       Impact factor: 9.408

2.  Serogroup A meningococcal conjugate vaccination in Burkina Faso: analysis of national surveillance data.

Authors:  Ryan T Novak; Jean Ludovic Kambou; Fabien Vk Diomandé; Tiga F Tarbangdo; Rasmata Ouédraogo-Traoré; Lassana Sangaré; Clement Lingani; Stacey W Martin; Cynthia Hatcher; Leonard W Mayer; F Marc Laforce; Fenella Avokey; Mamoudou H Djingarey; Nancy E Messonnier; Sylvestre R Tiendrébéogo; Thomas A Clark
Journal:  Lancet Infect Dis       Date:  2012-07-18       Impact factor: 25.071

3.  Time is (still) of the essence: quantifying the impact of emergency meningitis vaccination response in Katsina State, Nigeria.

Authors:  Matthew J Ferrari; Florence Fermon; Fabienne Nackers; Augusto Llosa; Claire Magone; Rebecca F Grais
Journal:  Int Health       Date:  2014-09-05       Impact factor: 2.473

4.  Conjugate Meningococcal Vaccines Development: GSK Biologicals Experience.

Authors:  Jacqueline M Miller; Narcisa Mesaros; Marie Van Der Wielen; Yaela Baine
Journal:  Adv Prev Med       Date:  2011-07-18

5.  Definition and characterization of localised meningitis epidemics in Burkina Faso: a longitudinal retrospective study.

Authors:  Haoua Tall; Stéphane Hugonnet; Philippe Donnen; Michèle Dramaix-Wilmet; Ludovic Kambou; Frank Drabo; Judith E Mueller
Journal:  BMC Infect Dis       Date:  2012-01-05       Impact factor: 3.090

6.  Serogroup W Meningitis Outbreak at the Subdistrict Level, Burkina Faso, 2012.

Authors:  Laurence Cibrelus; Isaïe Medah; Daouda Koussoubé; Denis Yélbeogo; Katya Fernandez; Clément Lingani; Mamoudou Djingarey; Stéphane Hugonnet
Journal:  Emerg Infect Dis       Date:  2015-11       Impact factor: 6.883

7.  Time delays in the response to the Neisseria meningitidis serogroup C outbreak in Nigeria - 2017.

Authors:  Assad Hassan; G U Mustapha; Bola B Lawal; Aliyu M Na'uzo; Raji Ismail; Eteng Womi-Eteng Oboma; Oyeronke Oyebanji; Jeremiah Agenyi; Chima Thomas; Muhammad Shakir Balogun; Mahmood M Dalhat; Patrick Nguku; Chikwe Ihekweazu
Journal:  PLoS One       Date:  2018-06-19       Impact factor: 3.240

8.  Neisseria meningitidis serogroup W, Burkina Faso, 2012.

Authors:  Jessica R MacNeil; Isaïe Medah; Daouda Koussoubé; Ryan T Novak; Amanda C Cohn; Fabien V K Diomandé; Denis Yelbeogo; Jean Ludovic Kambou; Tiga F Tarbangdo; Rasmata Ouédraogo-Traoré; Lassana Sangaré; Cynthia Hatcher; Jeni Vuong; Leonard W Mayer; Mamoudou H Djingarey; Thomas A Clark; Nancy E Messonnier
Journal:  Emerg Infect Dis       Date:  2014-03       Impact factor: 6.883

9.  Risk Assessment and Meningococcal A Conjugate Vaccine Introduction in Africa: The District Prioritization Tool.

Authors:  Laurence Cibrelus; Clément Lingani; Katya Fernandez; Mamoudou H Djingarey; William A Perea; Stéphane Hugonnet
Journal:  Clin Infect Dis       Date:  2015-11-15       Impact factor: 9.079

10.  Meningococcal Meningitis Outbreaks in the African Meningitis Belt After Meningococcal Serogroup A Conjugate Vaccine Introduction, 2011-2017.

Authors:  Katya Fernandez; Clément Lingani; Olaolu Moses Aderinola; Kadadé Goumbi; Brice Bicaba; Zewdu Assefa Edea; Clément Glèlè; Badu Sarkodie; Agbeko Tamekloe; Armelle Ngomba; Mamoudou Djingarey; Ado Bwaka; William Perea; Olivier Ronveaux
Journal:  J Infect Dis       Date:  2019-10-31       Impact factor: 5.226

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.